Terug
41
Dagbereik
€ 536,92
€ 549,50
52-Weeksbereik
€ 266,98
€ 549,50
Volume
528.650
50D / 200D Gem.
€ 491,10
/
€ 415,89
Vorige Slotkoers
€ 531,82
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 17,8 | 0,3 |
| P/B | 3,4 | 3,0 |
| ROE % | 19,7 | 3,7 |
| Net Margin % | 41,9 | 3,8 |
| Rev Growth 5Y % | 17,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 579,83
+7.1%
Low: € 447,00
High: € 645,00
Forward K/W
18,41
Forward WPA
€ 29,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,34B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 53,13
€ 46,51 – € 59,63
|
5,78B | 4 |
| FY2029 |
€ 46,47
€ 40,68 – € 52,15
|
5,06B | 4 |
| FY2028 |
€ 38,67
€ 27,43 – € 51,06
|
4,31B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | € 7,13 | € 7,70 | +8,0% |
| 2025-10-29 | € 6,89 | € 7,16 | +3,9% |
| 2025-07-30 | € 7,29 | € 6,41 | -12,1% |
| 2025-04-30 | € 6,29 | € 6,63 | +5,4% |
| 2025-02-26 | € 6,40 | € 6,19 | -3,3% |
| 2024-10-30 | € 6,43 | € 6,39 | -0,6% |
| 2024-07-31 | € 6,40 | € 5,85 | -8,6% |
| 2024-05-01 | € 5,65 | € 6,17 | +9,2% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 17,22% annually over 5 years — strong growth
ROE of 19,71% — decent returns on equity
Net margin of 41,94% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 1,04B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,61%
Groei
Revenue Growth (5Y)
17,22%
Revenue (1Y)10,61%
Earnings (1Y)11,68%
FCF Growth (3Y)17,99%
Kwaliteit
Return on Equity
19,71%
ROIC15,77%
Net Margin41,94%
Op. Margin46,89%
Veiligheid
Debt / Equity
0,00
Current Ratio6,60
Interest Coverage76,54
Waardering
P/E Ratio
17,78
Forward P/E18,41
P/B Ratio3,35
EV/EBITDA14,86
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,61% | Revenue Growth (3Y) | 16,94% |
| Earnings Growth (1Y) | 11,68% | Earnings Growth (3Y) | 16,42% |
| Revenue Growth (5Y) | 17,22% | Earnings Growth (5Y) | 29,42% |
| Profitability | |||
| Revenue (TTM) | 3,18B | Net Income (TTM) | 1,33B |
| ROE | 19,71% | ROA | 16,94% |
| Gross Margin | 87,92% | Operating Margin | 46,89% |
| Net Margin | 41,94% | Free Cash Flow (TTM) | 1,04B |
| ROIC | 15,77% | FCF Growth (3Y) | 17,99% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,60 |
| Interest Coverage | 76,54 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 17,78 | Forward P/E | 18,41 |
| P/B Ratio | 3,35 | P/S Ratio | 7,46 |
| PEG Ratio | 1,16 | Forward PEG | N/A |
| EV/EBITDA | 14,86 | Fwd EV/EBITDA | 9,66 |
| Forward P/S | 7,11 | Fwd Earnings Yield | 5,43% |
| FCF Yield | 4,38% | ||
| Market Cap | 23,74B | Enterprise Value | 22,18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,18B | 2,88B | 2,33B | 1,94B | 1,69B |
| Net Income | 1,33B | 1,20B | 984,80M | 727,30M | 475,80M |
| EPS (Diluted) | 27,86 | 24,64 | 19,81 | 15,00 | 10,06 |
| Gross Profit | 2,80B | 2,57B | 2,07B | 1,79B | 1,56B |
| Operating Income | 1,49B | 1,38B | 1,18B | 979,70M | 555,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7,88B | 7,36B | 7,17B | 6,04B | 5,17B |
| Total Liabilities | 783,80M | 920,00M | 1,18B | 1,25B | 1,21B |
| Shareholders' Equity | 7,10B | 6,44B | 5,98B | 4,80B | 3,96B |
| Total Debt | 0,0 | 300,00M | 700,00M | 800,00M | 800,00M |
| Cash & Equivalents | 1,56B | 1,70B | 1,21B | 961,20M | 894,80M |
| Current Assets | 3,70B | 3,87B | 3,55B | 3,38B | 2,32B |
| Current Liabilities | 560,60M | 738,10M | 804,40M | 343,20M | 305,40M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Balanced Risk
#105 of 151
Recente Activiteit
Ingestapt
Balanced Risk
Mar 24, 2026